
AstraZeneca Announces £300m UK Investment as Starmer Credits US Pharma Deal
AstraZeneca is investing £300m in UK operations, Prime Minister Keir Starmer announced at PMQs, protecting jobs in Cambridge and Macclesfield. The investment comes seven months after the company paused a £200m Cambridge expansion and is tied to a new US pharmaceutical deal requiring UK to pay 25% more for medicines by 2035. Meanwhile, NIESR warns the Iran war could cost the UK £35bn in GDP over 2026-2027.



